On Friday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was -3.70% drop from the session before settling in for the closing price of $1.35. A 52-week range for TNXP has been $1.08 – $60.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -17.05%. With a float of $2.99 million, this company’s outstanding shares have now reached $58.61 million.
The firm has a total of 103 workers. Let’s measure their productivity.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tonix Pharmaceuticals Holding Corp stocks. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.01%, while institutional ownership is 15.04%.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 3/31/2024, it has been observed that the corporation posted -85.76 earnings per share (EPS) during the time that was better than consensus figure (set at -88.16) by 2.4. Wall Street market experts anticipate that the next fiscal year will bring earnings of -6.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -17.05% per share during the next fiscal year.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
You can see what Tonix Pharmaceuticals Holding Corp (TNXP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.55, a number that is poised to hit -7.89 in the next quarter and is forecasted to reach -22.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Analysing the last 5-days average volume posted by the [Tonix Pharmaceuticals Holding Corp, TNXP], we can find that recorded value of 2.7 million was better than the volume posted last year of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 9.46%. Additionally, its Average True Range was 0.43.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 1.93%, which indicates a significant decrease from 4.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 320.49% in the past 14 days, which was higher than the 172.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.6676, while its 200-day Moving Average is $12.1629. Now, the first resistance to watch is $1.3533. This is followed by the second major resistance level at $1.4067. The third major resistance level sits at $1.4433. If the price goes on to break the first support level at $1.2633, it is likely to go to the next support level at $1.2267. Now, if the price goes above the second support level, the third support stands at $1.1733.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are 2,986K outstanding shares of the company, which has a market capitalization of 3.89 million. As of now, sales total 7,770 K while income totals -116,660 K. Its latest quarter income was 2,480 K while its last quarter net income were -14,940 K.
